Principal Financial Group Inc Emergent Bio Solutions Inc. Transaction History

Principal Financial Group Inc

  • $162 Billion
  • Q1 2024

A detailed history of Principal Financial Group Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 13,806 shares of EBS stock, worth $154,627. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,806
Previous 46,551 70.34%
Holding current value
$154,627
Previous $111,000 69.37%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024
SELL
$1.5 - $3.41 $49,117 - $111,660
-32,745 Reduced 70.34%
13,806 $34,000
Q4 2023

Feb 07, 2024
BUY
$1.82 - $3.16 $13,218 - $22,951
7,263 Added 18.49%
46,551 $111,000
Q3 2023

Nov 02, 2023
SELL
$3.17 - $7.91 $760,898 - $1.9 Million
-240,031 Reduced 85.93%
39,288 $133,000
Q2 2023

Aug 07, 2023
SELL
$7.35 - $13.21 $90,544 - $162,733
-12,319 Reduced 4.22%
279,319 $2.05 Million
Q1 2023

May 09, 2023
SELL
$7.79 - $16.29 $55,994 - $117,092
-7,188 Reduced 2.41%
291,638 $3.02 Million
Q4 2022

Feb 09, 2023
BUY
$11.0 - $21.45 $274,725 - $535,713
24,975 Added 9.12%
298,826 $3.53 Million
Q3 2022

Nov 09, 2022
SELL
$20.09 - $35.8 $48,195 - $85,884
-2,399 Reduced 0.87%
273,851 $5.75 Million
Q2 2022

Aug 10, 2022
SELL
$27.42 - $43.63 $1.09 Million - $1.73 Million
-39,766 Reduced 12.58%
276,250 $8.58 Million
Q1 2022

May 09, 2022
SELL
$36.48 - $52.22 $93,826 - $134,309
-2,572 Reduced 0.81%
316,016 $13 Million
Q4 2021

Feb 09, 2022
BUY
$33.11 - $55.01 $5.06 Million - $8.41 Million
152,961 Added 92.35%
318,588 $13.8 Million
Q3 2021

Nov 09, 2021
BUY
$50.07 - $66.05 $261,565 - $345,045
5,224 Added 3.26%
165,627 $8.29 Million
Q2 2021

Aug 10, 2021
SELL
$56.61 - $80.46 $781,387 - $1.11 Million
-13,803 Reduced 7.92%
160,403 $10.1 Million
Q1 2021

May 10, 2021
BUY
$86.23 - $125.19 $1.81 Million - $2.62 Million
20,962 Added 13.68%
174,206 $16.2 Million
Q4 2020

Feb 08, 2021
BUY
$79.17 - $111.47 $1.26 Million - $1.78 Million
15,958 Added 11.62%
153,244 $13.7 Million
Q3 2020

Nov 06, 2020
SELL
$81.91 - $134.94 $16.7 Million - $27.4 Million
-203,378 Reduced 59.7%
137,286 $14.2 Million
Q2 2020

Aug 05, 2020
SELL
$54.33 - $89.52 $350,265 - $577,135
-6,447 Reduced 1.86%
340,664 $26.9 Million
Q1 2020

May 12, 2020
SELL
$49.34 - $68.76 $683,013 - $951,844
-13,843 Reduced 3.84%
347,111 $20.1 Million
Q4 2019

Feb 05, 2020
BUY
$51.21 - $59.06 $364,871 - $420,802
7,125 Added 2.01%
360,954 $19.5 Million
Q3 2019

Nov 13, 2019
SELL
$40.6 - $57.2 $628,041 - $884,826
-15,469 Reduced 4.19%
353,829 $18.5 Million
Q2 2019

Aug 12, 2019
SELL
$39.92 - $53.86 $657,522 - $887,128
-16,471 Reduced 4.27%
369,298 $17.8 Million
Q1 2019

May 10, 2019
SELL
$48.23 - $66.16 $84,354 - $115,713
-1,749 Reduced 0.45%
385,769 $19.5 Million
Q4 2018

Feb 14, 2019
BUY
$55.63 - $73.24 $216,623 - $285,196
3,894 Added 1.02%
387,518 $23 Million
Q3 2018

Nov 14, 2018
BUY
$52.05 - $66.51 $4.29 Million - $5.48 Million
82,430 Added 27.37%
383,624 $25.3 Million
Q2 2018

Aug 13, 2018
BUY
$48.33 - $55.64 $440,721 - $507,381
9,119 Added 3.12%
301,194 $0
Q1 2018

May 14, 2018
BUY
$44.44 - $54.39 $327,389 - $400,691
7,367 Added 2.59%
292,075 $15.4 Million
Q4 2017

Feb 13, 2018
BUY
$37.77 - $47.75 $747,506 - $945,020
19,791 Added 7.47%
284,708 $13.2 Million
Q3 2017

Nov 02, 2017
BUY
$34.14 - $40.45 $9.04 Million - $10.7 Million
264,917
264,917 $10.7 Million

Others Institutions Holding EBS

# of Institutions
139
Shares Held
35.2M
Call Options Held
78.7K
Put Options Held
75.1K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $558M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email